13D Filing: Farallon Capital and Radius Health Inc. (RDUS)

Page 29 of 45

Page 29 of 45 – SEC Filing

(c) The principal business of each of the Farallon Funds is that of a private investment fund engaging in the purchase and sale of investments for its own account.  The principal business of the Management Company is that of a registered investment adviser.  The principal business of the Farallon General Partner is to act as the general partner of investment partnerships, including FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI, and as the sole member of investment partnership general partners, including the FCIP V General Partner. The principal business of the FCIP V General Partner is to act as the general partner of FCIP V. The principal business of the F5MI General Partner is to act as the general partner of F5MI. The principal business of each of the Farallon Individual Reporting Persons is set forth in Annex 1 hereto.
(d) None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) None of the Reporting Persons has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f) The citizenship of each of the Farallon Funds, the Management Company, the Farallon General Partner, the FCIP V General Partner and the F5MI General Partner is set forth above.  Each of the Farallon Individual Reporting Persons, other than Spokes, is a citizen of the United States.  Spokes is a citizen of the United Kingdom.
The other information required by Item 2 relating to the identity and background of the Reporting Persons is set forth in Annex 1 hereto.
Item 3.Source and Amount of Funds or Other Consideration
Item 3 is amended and restated in its entirety as follows:
The net investment cost (including commissions) for the Shares acquired by each of the Farallon Funds and the Managed Accounts is set forth below:
Entity
Shares Acquired
Approximate Net Investment Cost
FCP
803,800
$32,434,389
FCIP
796,272
$32,840,369
FCIP II
135,300
$5,703,559
FCIP III
115,100
$5,023,973
FCIP V
97,900
$4,086,547
FCOI II
1,443,645
$58,103,653
FCAMI
59,900
$2,464,594
F5MI
75,183
$3,471,959
Managed Accounts
51,900
$2,247,805
3,579,000
$146,376,848
The consideration for such acquisitions was obtained as follows:  (i) with respect to FCP, FCOI II, FCAMI, F5MI and the Managed Accounts, from working capital and/or from borrowings pursuant to margin accounts maintained in the ordinary course of business by such entities at Goldman, Sachs & Co.; and (ii) with respect to FCIP, FCIP II, FCIP III and FCIP V,

Follow Radius Health Inc. (NASDAQ:RDUS)

Page 29 of 45